PSID - PositiveID Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.0005
0.0000 (0.00%)
At close: 2:38PM EDT
Stock chart is not supported by your current browser
Previous Close0.0005
Open0.0005
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0004 - 0.0005
52 Week Range0.0003 - 28.0000
Volume6,863,644
Avg. Volume10,202,309
Market Cap4,696
Beta1.86
PE Ratio (TTM)N/A
EPS (TTM)-18.4420
Earnings DateApr 2, 2018 - Apr 6, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2008-08-29
1y Target Est10.00
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    PositiveID Adds Listeria to Pathogens Detected by FireflyDX Onsite Detection Prototype

    PositiveID Corporation’s (“PositiveID” or “Company”) (PSID) ExcitePCR subsidiary today announced it successfully tested for Listeria bacterium on its FireflyDX breadboard prototype pathogen detection system (“prototype system”), being developed to detect pathogens at the point of need, which in this case could be a food processing facility. Listeria was amplified on the FireflyDX prototype system using fluorescence resonance energy transfer (FRET) chemistry. Listeriosis is a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes, most commonly found in dairy products and produce.

  • GlobeNewswire3 months ago

    PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection

    PositiveID Corporation (“PositiveID” or “Company”) (PSID) announced today its ExcitePCR subsidiary has joined Cambridge Healthtech Institute’s meeting of internationally recognized experts in detection and biological threats, Biodetection Technologies: Biothreat and Pathogen Detection, to be held in Bethesda, MD June 27-28th. ExcitePCR Chief Science Officer Kimothy Smith DVM, Ph.D., will participate in a discussion centered on cutting-edge strategies to overcoming hurdles to global biological threats defense and detection, and obstacles faced in getting detection technologies from lab to field, such as ExcitePCR’s FireflyDX family of point-of-care (POC) pathogen detection. ExcitePCR is developing the FireflyDX family of pathogen detection systems, portable devices offering rapid sample-to-result detection in less than 30 minutes using real-time polymerase chain reaction (PCR) chemistry at the point-of-need or point-of-care.

  • Masimo and PositiveID Announce the U.S. Release of TIR-1™
    Business Wire3 months ago

    Masimo and PositiveID Announce the U.S. Release of TIR-1™

    Masimo  and Thermomedics, a PositiveID company, announced today the debut and U.S. market release of TIR-1™, a non-contact Bluetooth®-enabled thermometer that integrates seamlessly with the Masimo Root® patient monitoring and connectivity platform.